Cordova Ashley - Mar 3, 2022 Form 4 Insider Report for NovoCure Ltd (NVCR)

Role
Chief Financial Officer
Signature
By: /s/ Steven Robbins, Attorney in Fact for Ashley Cordova
Stock symbol
NVCR
Transactions as of
Mar 3, 2022
Transactions value $
$0
Form type
4
Date filed
3/11/2022, 03:55 PM
Previous filing
Jan 12, 2022
Next filing
Mar 9, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NVCR Ordinary Shares Options Exercise $59.9K +3.84K +6.31% $15.60 64.7K Mar 3, 2022 Direct
transaction NVCR Ordinary Shares Options Exercise $13.8K +1.2K +1.86% $11.46 65.9K Mar 3, 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NVCR Options to Buy Ordinary Shares Options Exercise -$59.9K -3.84K -100% $15.60 0 Mar 3, 2022 Ordinary Shares 3.84K $15.60 Direct F1
transaction NVCR Options to Buy Ordinary Shares Options Exercise -$13.8K -1.2K -13.43% $11.46 7.74K Mar 3, 2022 Ordinary Shares 1.2K $11.46 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Fully vested as of the date hereof.